* By Madison Alworth*
Gina Gershon is taking on a new challenge, performing a live jazz show at the celebrated Upper East Side cabaret Café Carlyle.
"Hopefully you can expect really amazing music, I know that," said Gershon, whose 30-plus year acting career has included a number of fiery roles. "I've got an incredible jazz band. I could do nothing but listen to those guys and everyone would have a really good time."
Gershon can also be seen on the big screen in the blockbuster comedy, "Blockers." She said she had a blast filming her supporting role, though she admits she has yet to see the movie in the theater. She is perhaps best known for her role in Paul Verhoeven's "Showgirls," alongside Arnold Schwarzenegger in "Red Heat," and opposite Tom Cruise in "Cocktail."
Her new show at Café Carlyle is a decidedly different experience than her 1980s and 90s movie roles.
"It can't get much more live than people like eating dinner under your face as you're singing your guts out," said Gershon. "You don't know what's going to happen."
To see what happens, you can stop by Café Carlyle June 5 - 16 to see Gershon's show, "Wild Women Don't Get the Blues."
Soundhound AI co-founder, president, and CEO Keyvan Mojaver discusses bringing its audio tools to cars and drive-thrus, plus why smaller companies may benefit from the A.I. boom.
Deiya Pernas, co-founder of Pernas Research, breaks down Nvidia’s blockbuster earnings, why energy is a sector to watch, and why the A.I. trend is far from over.
The NBA is organizing its next media rights deal to figure out which networks and streaming services will show their games for the next decade. Last time, most of the prominent streaming services didn't exist yet.
Jessica Traver Ingram, CEO and co-founder of IntuiTap Medical, discusses developing the company's Ver Touch device, the crucial FDA approval it just won, and why innovation in spinal blocks and epidurals is long overdue.
Matt Stucky, Chief Portfolio Manager of Equities at Northwestern Mutual Wealth Management chats why Nvidia has been unsteady leading up to its latest earnings results, plus what’s to come for the so-called ‘Magnificent 7.’
